Evidence map›Paper›PMID 36918131›Full record

ArticleAmerican journal of preventive medicine2023

Increasing Use of Cannabis for Medical Purposes Among U.S. Residents, 2013-2020.

Taeho Greg Rhee, Robert A Rosenheck

Open access · greenAbstract read
In one paragraph

Article in American journal of preventive medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Impact of cannabis use on health outcomes and prescription benzodiazepine use.medRxiv : the preprint server for health sciences · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Virulence of Five Root-Knot Nematodes (Plants (Basel, Switzerland) · 2025
    Article
  14. Article
  15. Cannabis tolerance reduces symptom relief.Frontiers in pharmacology · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Taeho Greg RheeDepartment of Psychiatry, Yale School of Medicine, New Haven, Connecticut; VA New England Mental Illness, Research, Education and Clinical Center (MIRECC), VA Connecticut Healthcare System, West Haven, Connecticut; Department of Public Health Sciences, School of Medicine, University of Connecticut, Farmington, Connecticut. Electronic address: tgrhee.research@gmail.com.
Robert A RosenheckDepartment of Psychiatry, Yale School of Medicine, New Haven, Connecticut; VA New England Mental Illness, Research, Education and Clinical Center (MIRECC), VA Connecticut Healthcare System, West Haven, Connecticut.
University of Connecticut · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Training Program in Geriatric Clinical Epidemiology and Aging-Related ResearchT32AG019134 · NIA · YALE UNIVERSITY · PI Terri R. Fried · 2001 to 2026
$7.5M
Effects of electroconvulsive therapy on suicide in geriatrics patients with major depressive disorder: a nationwide cohort study using propensity score matching and instrumental variable analysisR21MH117438 · NIMH · YALE UNIVERSITY · PI WILKINSON, SAMUEL · 2019 to 2020
$682k
Impact of cannabis legalization on prescription drug use and health outcomes in ConnecticutR21DA057540 · NIDA · YALE UNIVERSITY · PI RADHAKRISHNAN, RAJIV, RHEE, TAEHO GREGORY · 2023 to 2024
$475k
Associations of Opioid Prescribing with Long-term Functional Outcomes and Mortality Rates in Older Nursing Home ResidentsR21AG070666 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI RHEE, TAEHO GREGORY · 2021 to 2022
$295k
NCATS NIH HHS UL1 TR001863NIA NIH HHS R21 AG070666NIA NIH HHS T32 AG019134NIDA NIH HHS R21 DA057540NIMH NIH HHS R21 MH117438
6 · The paper itself

Abstract

introductionCannabis use for medical purposes is legalized across 39 states and the District of Columbia in the U.S. The objective of this study was to evaluate temporal trends and correlates of cannabis use for medical purposes in the U.S.

methodsData from the 2013-2020 National Survey on Drug Use and Health were used. Since 2013, medical cannabis use has been assessed using a dichotomous question asking whether any medical cannabis use was recommended by a doctor among those who used cannabis in the past 12 months. A modified Poisson model was used to estimate the average annual percentage change in medical cannabis use from 2013 to 2020. The analyses were repeated for key sociodemographic and clinical subgroups. Data were analyzed from September to November 2022.

resultsThe prevalence of U.S. residents using cannabis for medical purposes increased significantly from 1.2% in 2013-2014 to 2.5% in 2019-2020, with an average annual percentage change of 12.9% (95% CI=10.4, 15.5), and many of sociodemographic and clinical subgroups showed similar significant increases in cannabis use for medical purposes. In the multivariable-adjusted model, living in a state that legalized medical cannabis remained significantly associated with medical cannabis use (AOR=4.10; 95% CI=3.68, 4.56).

conclusionsThe study documents a continued nationwide increase in the use of cannabis for diverse medical purposes between 2013 and 2020, two decades after the first state passed legalizing legislation.

Indexed as

CannabisMedical MarijuanaSubstance-Related DisordersDistrict of ColumbiaHumansPrevalenceMedical Marijuana

Identifiers

PMID36918131
PMCPMC10440227
OpenAlexW4323975529

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.